As part of Turning Point’s Ketamine Awareness Campaign, we’re hosting a focused webinar to support early intervention and harm reduction efforts.
Ketamine use is rising, and its long-term effects are becoming more visible across healthcare settings. This session is designed for GPs, pharmacists, A&E clinicians, and other frontline professionals to help recognise when ketamine use may be causing harm — and to encourage timely engagement with drug and alcohol services.
Hosted by: Dr Martyn Hull, Clinical Director, Turning Point
Webinar Focus:
- Urinary health impacts of ketamine
Alison Downey, Consultant Urologist at Mid Yorkshire NHS Teaching Trust will share clinical insights into diagnosis, treatment options, and when uropathy becomes irreversible — highlighting the importance of early intervention. - Recreational use and harm reduction
Lydia Plant, CEO at Bristol Drug Project (BDP), will discuss why people use ketamine, what motivates them to seek support, and how to engage patients effectively using evidence-based harm reduction approaches. - Lived experience case studies
Hear directly from individuals who have navigated ketamine-related health issues and accessed support services.
Whether you’re seeing patients in primary care, emergency departments, or community settings, this webinar will equip you with the tools to respond confidently and compassionately.
Please share this invitation with colleagues who may find it helpful. If you’re unable to attend, register anyway and we’ll send you the recording.